Novan Announces Proposed Public Offering of Common Stock and Warrants
January 04, 2018 16:07 ET
|
Novan, Inc.
MORRISVILLE, N.C., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that it intends to offer and sell, subject to market and other conditions,...
Novan Announces First Patient Dosed in Phase 1b Atopic Dermatitis Trial with SB414
December 05, 2017 08:35 ET
|
Novan, Inc.
MORRISVILLE, N.C., Dec. 05, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that the first patient has been dosed in the Company's Phase 1b clinical...
Novan to Present at Piper Jaffray 29th Annual Healthcare Conference
November 22, 2017 08:25 ET
|
Novan, Inc.
MORRISVILLE, N.C., Nov. 22, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that Nathan Stasko, PhD, President and Chief Scientific Officer of Novan, is...
Novan Announces Plan to Complete Development of SB204 Acne Candidate via Third Party Funding and Execution
November 07, 2017 08:05 ET
|
Novan, Inc.
MORRISVILLE, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that it has agreed in principle to a business structure that would enable...
Novan Acquires IP Rights to Treat Viral Malignancies with Nitric Oxide
October 18, 2017 07:05 ET
|
Novan, Inc.
Expanded Indications in Field of Virology Build on SB206 Clinical Success Against Human Papillomavirus Company Doses First Patient in Inflammatory Skin Disease Program in Phase 1b Psoriasis Trial...
Novan Announces Corporate Update Conference Call and Webcast
October 13, 2017 08:35 ET
|
Novan, Inc.
MORRISVILLE, N.C., Oct. 13, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that the Company will host a conference call on Wednesday, October 18, at...
Machelle Sanders Appointed to Novan Board of Directors
September 26, 2017 08:30 ET
|
Novan, Inc.
MORRISVILLE, N.C., Sept. 26, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced the appointment of Machelle Sanders to the Company’s Board of Directors....
Novan Conducts Guidance Meeting with FDA on SB204 Development Program
September 25, 2017 08:00 ET
|
Novan, Inc.
MORRISVILLE, N.C., Sept. 25, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that it has concluded a guidance meeting with the U.S. Food and Drug...
Novan Appoints Paula Brown Stafford, Chief Development Officer, to Board of Directors
August 16, 2017 08:05 ET
|
Novan, Inc.
MORRISVILLE, N.C., Aug. 16, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that Paula Brown Stafford has been appointed to the Company’s Board of...
Novan Announces Corporate Update Conference Call and Webcast
July 25, 2017 16:05 ET
|
Novan, Inc.
MORRISVILLE, N.C., July 25, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that the Company will host a conference call on Wednesday, Aug. 2, at 8:30...